Overexpression of kin of IRRE-Like protein 1 (KIRREL) as a prognostic biomarker for breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overexpression of kin of IRRE-Like protein 1 (KIRREL) as a prognostic biomarker for breast cancer

Published:2020-07 Issue:7 Volume:216 Page:153000
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Chen Kexin,Zhao Rui,Yao Guodong,Liu Zhao,Shi Runze,Geng Jingshu

Funder

Post graduate research

practice innovation project of Harbin Medical University

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference28 articles.

1. Cancer screening in the United States, 2018: a review of current American cancer society guidelines and current issues in cancer screening;Smith;CA Cancer J. Clin.,2018

2. Local cancer recurrence: the realities, challenges, and opportunities for new therapies;Mahvi;CA Cancer J. Clin.,2018

3. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment;Greenlee;CA Cancer J. Clin.,2017

4. Cancer treatment and survivorship statistics;Miller;CA Cancer J. Clin.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway;Journal of Cellular and Molecular Medicine;2023-11

2. Identification of biomarkers for breast cancer early diagnosis based on the molecular classification using machine learning algorithms on transcriptomic data and factorial designs for analysis;2023-05-12

3. An Immunohistochemical Study of Breast Cancer Brain Metastases: The Role of CD44 and AKT in the Prognosis;Applied Immunohistochemistry & Molecular Morphology;2023-04-21

4. Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours;Scientific Reports;2022-12-03

5. Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes;Clinical Epigenetics;2022-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3